University of Ottawa

- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 1848-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.uottawa.ca
Clinical Trials
104
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (99 trials with phase data)• Click on a phase to view related trials
Identifying the Limits of Survivability in Heat-exposed Older Females
- Conditions
- Heat StressAgingTemperature Change, BodyThermoregulationHeat Exposure
- First Posted Date
- 2025-06-24
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- University of Ottawa
- Target Recruit Count
- 12
- Registration Number
- NCT07032493
- Locations
- 🇨🇦
University of Ottawa, Ottawa, Ontario, Canada
Social Prescribing for Advancing Resilience in Kids: A Pilot Study of Social Prescribing
- Conditions
- Youth Mental Health and WellbeingFeasibility and Acceptability of the Social Prescribing Program
- First Posted Date
- 2025-06-15
- Last Posted Date
- 2025-06-15
- Lead Sponsor
- University of Ottawa
- Target Recruit Count
- 170
- Registration Number
- NCT07022561
- Locations
- 🇨🇦
University of Ottawa, Ottawa, Ontario, Canada
Hypoxia, Appetite, and Energy Intake in Young Female Adults
- Conditions
- HypoxiaAltitudeAppetiteEnergy Intake
- First Posted Date
- 2025-04-04
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- University of Ottawa
- Target Recruit Count
- 10
- Registration Number
- NCT06912230
- Locations
- 🇨🇦
Behavioural and Metabolic Research Unit, School of Human Kinetics, Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada
Adapting the Fear of Recurrence Therapy (FORT) for Parents and Establishing Acceptability and Feasibility
- Conditions
- CancerParentFear of Cancer RecurrenceCBTChildhood Cancer Survivors
- First Posted Date
- 2025-03-12
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- University of Ottawa
- Target Recruit Count
- 36
- Registration Number
- NCT06872840
- Locations
- 🇨🇦
University of Ottawa, Ottawa, Ontario, Canada
Robot-based Intervention to Improve Physical Activity in Older Adults
- Conditions
- Physical InactivityAgingSedentary BehaviorsBias, ImplicitCognition
- First Posted Date
- 2025-02-24
- Last Posted Date
- 2025-03-04
- Lead Sponsor
- University of Ottawa
- Target Recruit Count
- 40
- Registration Number
- NCT06843161
- Locations
- 🇨🇦
Faculty of Health Sciences, Ottawa, Ontario, Canada
- Prev
- 1
- 2
- 3
- 4
- 5
- 21
- Next
News
Heavy Cannabis Use Linked to Triple Mortality Risk and Rising Psychosis Cases, Studies Find
People diagnosed with cannabis use disorder (CUD) face nearly triple the risk of death over five years compared to the general population, with a tenfold increase in suicide risk, according to a large Canadian study.
ER Visits for Psychedelics Linked to Higher Mortality and Schizophrenia Risk, Studies Find
Emergency room patients treated for psychedelic use face a 2.6-fold higher risk of death within five years compared to the general population, with particularly elevated risks for suicide, cancer, and overdose.
Hypovolemic Phlebotomy Reduces Transfusion Needs in Liver Surgery
A clinical trial demonstrates that removing approximately 10% of a patient's blood before liver surgery significantly reduces the need for blood transfusions during the procedure.
Aerobic Exercise During Chemotherapy May Improve Cognitive Function in Breast Cancer Patients
• Women undergoing chemotherapy for breast cancer reported improved cognitive function when participating in an aerobic exercise program, according to the ACTIVATE trial. • The study found that patients who started aerobic exercise alongside chemotherapy experienced better self-reported mental abilities compared to those receiving standard care alone. • Objective neuropsychological testing showed similar cognitive performance between the exercise and standard care groups, but exercise still improved quality of life. • Researchers suggest integrating exercise assessment and referral into routine cancer care to support both physical and mental health during and after treatment.
Edaravone Shows Promise in Targeting Glioblastoma Stem Cells
A recent study indicates that edaravone, an existing ALS drug, can be repurposed to target brain tumor stem cells (BTSCs) in glioblastoma.